There are over 600 neurological conditions affecting children in Australia. Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. The healthcare journey can often be challenging and isolating, and has a profound impact on health, psychosocial and economic wellbeing for the child and wider family.
The UNSW child neurology research group utilize innovative scientific technologies alongside clinical learnings and education to improve health outcomes for children affected by neurological disorders, so that they and their families can live happy and fulfilling lives.
Paediatric Neurology is a multidisciplinary research group consisting of clinicians and researchers from the Department of Neurology at the Sydney Children’s Hospital Network and the School of Clinical Medicine UNSW Sydney. Our research is driven by clinical challenges faced by healthcare practitioners, parents and children with neurological disorders.
Our program currently aims to utilise learnings from Spinal Muscular Atrophy (SMA) to progress clinical trial and treatment approaches for rare genetic neurological disorders, increase collaborative networks and build workforce capacity. This will broaden the clinical translation of new therapeutics so that Australia is at the forefront of realising the benefits of precision medicine.
Our strategy involves connecting clinicians and researchers across disciplines as well as integrating health implementation and translation approaches for:
We are a team of clinician and scientist researchers, focused on helping children benefit as soon as possible from developments in therapeutics for rare and complex diseases in childhood (neuromuscular, neurodegenerative and neurodevelopmental). We have expertise in clinical phenotyping, conduct of clinical trials and applying research to facilitate improvements in health practice and outcomes for patients, their families and the community.